Cover image of the article: Accidental Levothyroxine Ingestion in a Child

Image Credit:Inn J Pediatr

Accidental Levothyroxine Ingestion in a Child

Authors

K JAGADISHKUMAR1,*, Vaddambal G. Manjunath2, Nagaraj Rashmi 3, Sangaraju Mamatha 4
*Corresponding Author: Email: jagdishmandya@gmail.com

Innovative Journal of Pediatrics:Vol. 23, issue 6; 711-712
Published online:Oct 18, 2013
Article type:Letter
Received:Nov 27, 2012
Accepted:Feb 06, 2013
How to Cite:JAGADISHKUMAR K, G. Manjunath V, Rashmi N, Mamatha S. Accidental Levothyroxine Ingestion in a Child. Inn J Pediatr. 2013;23(6):. doi:

Abstract

Fulltext

Hypothyroidism is one of the most common endocrine disorders, and many levothyroxine prescriptions are written to replace the hormone deficit. Herewith we report a thyroid hormone overdose in a 6 year old boy.
6 year old Beckwith-Wiedeman syndrome boy with developmental delay presented with accidental ingestion of 2.5 mg of levothyroxine 6 hours prior to admission. He has been receiving levothyroxine for hypothyroidism since neonatal period and currently (weight=17 kgs) he was on 100 μg of levothyroxine once a day. There were no tremors, irritability, convulsions or diarrhea. On examination his temperature was 98.6ᵒF, pulse rate 100/min, RR 20/min and BP was 100/60 mm Hg. Other systems examination was unremarkable. His Thyroid profile is shown in Table 1. Gastric lavage and gastrointestinal decontamination was done. His complete blood count, blood sugar, blood urea, serum creatinine, Aspartate transaminase (SGOT), lactate dehydrogenase (LDH), creatine kinase MB (CK-MB) and electrocardiography were within normal limits. He was monitored for overdose features. After 24 hours he was tachycardic (PR 120/min), febrile (99.60F) with blood pressure 112/80mm Hg (>95th centile) along with sweating of palms and soles. In view of tachycardia, sweating and hypertension, Propranolol and Dexamethasone was started. After 76 hours features of thyroid toxicity subsided and drugs were tapered. Child was restarted on thyroxine and discharged on 8thday. Child was followed up at 3 and 6 months, there was no feature of hypothyroidism.
Levothyroxine overdose in children typically follows a benign course[1]. Children may be asymptomatic or have clinical features like fever, tachycardia, hypertension, tremor, insomnia, irritability and convulsions[1-3]. Our patient had typical clinical features like tachycardia, sweating  
Table 1: Thyroid profile following accidental consumption of Levothyroxine
 
and hypertension. Annual report of the American Association of Poison Control Centers' National Poison Data System of 2008 revealed that out of 9,006 unique exposures to thyroid preparations only 3 cases had major adverse outcome and there were no deaths[4]. It has been documented that there is no correlation between the amount of levothyroxine ingested and the onset and severity of the symptoms as well as the serum concentrations of both triiodothyronine (T3) and thyroxine (T4)[2,5-7]. In study by Golighty et al one child with massive ingestion (13mg) never developed any complications whereas ingestion of 1.8mg developed tachycardia[5]. Serum T4 levels can help only in verifying the occurrence of the ingestion[5,6]. In many pediatric levothyroxine ingestion study series either they did not develop symptoms or showed only minimal symptoms[2,3-6]. In a study by Livotiz et al only four out of 78 children developed symptoms and T4 levels in three of these four children were 32.8, 30 and 26.4 μg/dl, respectively[2] which were similar to T4 levels in our child. Literature has supported a conservative management based on minimal symptoms[2,5,6]. T4 values cannot be used to guide treatment, and prompt clinical monitoring and evaluation is necessary[5]. Propranolol is used in the presence of features of toxicity[3,5]. Julio Pardo opines thyroxine overdose needs very close monitoring after gastrointestinal decontamination and conser-vative treatment like propranolol, prednisone, etc should be started as soon as the patient becomes symp-tomatic to avoid the development of a thyroid storm[7]. In children with overdosage of levothyroxine, there is production of reverse T3 which is inactive, thereby protecting from the toxicity and this pathway is enhanced by steroids supporting addition of steroids to the treatment regimen[3,8]. To conclude although pediatric levothyroxine overdose rarely leads to serious toxicity, any symptoms should be managed accordingly as they arise.

References

  • 1.
    References are available on the PDF.

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

21
Aug
2024
Treatment Challenges of Methimazole-Induced Agranulocytosis in Younger Patients

Treatment Challenges of Methimazole-Induced Agranulocytosis in Younger Patients

Azadeh Kiumarsi,
Reza Mohamadhosseinzadeh Davatgari,
Maryam Habibi,
Mahsa Soti Khiabani

Kiumarsi A, Mohamadhosseinzadeh Davatgari R, Habibi M, Soti Khiabani M. Treatment Challenges of Methimazole-Induced Agranulocytosis in Younger Patients. Inn J Pediatr. 2024;34(5):e140262. doi: https://doi.org/10.5812/ijp-140262

31
Jan
2007
Liver Cholestasis in Thyrotoxicosis: a Case Report

Liver Cholestasis in Thyrotoxicosis: a Case Report

GK Sjberg,
P Katzman,
B Hallengren

Sjberg G, Katzman P, Hallengren B. Liver Cholestasis in Thyrotoxicosis: a Case Report. Int J Endocrinol Metab. 2007;5(1):. doi:

31
Oct
2015
Report of Severe Menorrhagia Following the Maximum Amount of Lamotrigine Overdose

Report of Severe Menorrhagia Following the Maximum Amount of Lamotrigine Overdose

Farid Hajiali,
Marjan Nassiri-Asl

Hajiali F, Nassiri-Asl M. Report of Severe Menorrhagia Following the Maximum Amount of Lamotrigine Overdose. Iran J Pharm Res. 2015;14(4):e125368. doi: https://doi.org/10.22037/ijpr.2015.1749

30
Apr
2006
Methimazole-Induced Agranulocytosis in a Mother and her Young Daughter, the Possible Role of Genetic Factors in the Development of Methimazole- Induced Agranulocytosis

Methimazole-Induced Agranulocytosis in a Mother and her Young Daughter, the Possible Role of Genetic Factors in the Development of Methimazole- Induced Agranulocytosis

A Bahrami

Bahrami A. Methimazole-Induced Agranulocytosis in a Mother and her Young Daughter, the Possible Role of Genetic Factors in the Development of Methimazole- Induced Agranulocytosis. Int J Endocrinol Metab. 2006;4(2):. doi:

30
Mar
2015
Neuraxial Dexmedetomidine: Wonder Drug or Simply Harmful

Neuraxial Dexmedetomidine: Wonder Drug or Simply Harmful

Sohan Lal Solanki,
Vipin Kumar Goyal

Solanki SL, Goyal VK. Neuraxial Dexmedetomidine: Wonder Drug or Simply Harmful. Anesth Pain Med. 2015;5(2):e22651. doi: https://doi.org/10.5812/aapm.22651

More by these authors

K JAGADISHKUMARPubMedScholar
Vaddambal G. ManjunathPubMedScholar
Nagaraj RashmiPubMedScholar
Sangaraju MamathaPubMedScholar
Share
Cited by
Metrics